Michael Machuzak, MD
Pulmonary Disease · Cleveland, OHNPI 1851355085
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Olympus Corporation Of The Americas accounts for 63.5% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2019 at $88,038 and has fallen 68.6% since, to $27,614 in 2025. Among pulmonary disease clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 443 payments — averaging $645.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$182K
- Johnson & Johnson$36K
- Medical Device Business Services, Inc.$22K
- Olympus America Inc.$18K
- Olympus Medical Systems Corporation$7K
- Serpex Medical Inc$7K
- plus $14K from 18 others
Across 23 payments — averaging $4541.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Johnson & Johnson$69K
- Ethicon Endo-surgery Inc.$19K
- Pulmonx Corporation$17K
What the payments were for
- Consulting fees$97,74534%
- Speaking & faculty fees$4400%
- Travel & lodging$20,4797%
- Food & beverage$9,6193%
- Education$157,70355%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 259 | $181,680 |
| Johnson & Johnson(2 entities) | 43 | $36,241 |
| Medical Device Business Services, Inc. | 32 | $22,272 |
| Olympus America Inc. | 29 | $17,659 |
| Olympus Medical Systems Corporation | 4 | $7,150 |
| Serpex Medical Inc | 6 | $6,625 |
| Body Vision Medical Inc. | 10 | $4,543 |
| Gyrus ACMI, Inc. | 6 | $3,630 |
| Ethicon Endo-surgery Inc. | 4 | $1,366 |
| Olympus Corporation | 3 | $1,043 |
| Noah Medical Corporation | 6 | $650 |
| Boston Scientific | 15 | $646 |
| Pulmonx Corporation | 5 | $486 |
| Intuitive Surgical | 4 | $450 |
| Veran Medical Technologies, Inc. | 1 | $440 |
| Merit Medical Systems Inc | 1 | $350 |
| Auris Health, Inc. | 3 | $227 |
| Getinge USA Sales, LLC | 3 | $159 |
| Ambu Inc. | 1 | $118 |
| Covidien LP | 4 | $114 |
| Philips North America LLC | 1 | $97 |
| ICU Medical Inc | 1 | $16 |
| Genentech USA, Inc. | 1 | $14 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINGLE USE SUCTION VALVE (Sterile)$89,370
- Olympus Respiratory Accessories$84,662
- Olympus EBUS Bronchoscopes$71,158
- Olympus Capital Accessories$69,103
- Olympus Bronchoscopes$68,372
- MONARCH$49,909
- Olympus$33,212
- Single Use Aspiration Needle$26,576
- Single Use Aspiration Needle NA-U401SX$21,451
- Single Use Guide Sheath Kit$16,706
- EVIS EXERA$15,400
- Monarch Platform$6,658
- EVES EUS ULTRASOUND BRONCHOFIBERVIDEOSCOPE$4,370
- LungVision$4,061
- ViziShot 2 FLEX$3,341
- Spiration Valve System$3,190
- Neuwave$1,366
- Respiratory Accessories$880
- Respiratory Core Devices$880
- Respiratory Needles$880
How this compares
$285,986 in reported general payments places this provider in the 95th percentile of 571 pulmonary disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $7,681 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Cleveland
- Kristin HighlandCleveland$551K
- Joseph CiceniaCleveland$350K
- Marie BudevCleveland$159K
- Leslie TolleCleveland$136K
- Elliott DasenbrookCleveland$114K
- James StollerCleveland$101K
- Gustavo Heresi DavilaCleveland$98K
- Bryan BennCleveland$96K
- Thomas GildeaCleveland$69K
- Daniel CulverCleveland$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.